Angiogenesis and surgery: from mice to man.
Drixler
T A
TA
Department of Surgery, University Medical Centre, Utrecht, The Netherlands.
Voest
E E
EE
van Vroonhoven
T J
TJ
Borel Rinkes
I H
IH
D020533:Angiogenesis Inhibitors / Q000378:metabolism* / Q000627:therapeutic use*; D043168:Angiostatins; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism; D002199:Capillary Permeability; D003094:Collagen / Q000502:physiology; D043169:Endostatins; D005544:Forecasting; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D008666:Metalloendopeptidases / Q000378:metabolism; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D010446:Peptide Fragments / Q000378:metabolism / Q000502:physiology; D010958:Plasminogen / Q000378:metabolism; D011480:Protease Inhibitors / Q000378:metabolism; D019699:Thrombospondins / Q000502:physiology; D014945:Wound Healing / Q000502:physiology
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D043169:Endostatins; D006133:Growth Substances; D010446:Peptide Fragments; D011480:Protease Inhibitors; D019699:Thrombospondins; D043168:Angiostatins; D010958:Plasminogen; D003094:Collagen; D008666:Metalloendopeptidases